Literature DB >> 2494996

Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo.

U F Schade1, M Ernst, M Reinke, D T Wolter.   

Abstract

Injection of endotoxin in D-galactosamine sensitized mice resulted in increased serum levels of tumor necrosis factor as determined in a fibroblast cytolysis assay. Concomitant injection of different lipoxygenase inhibitors decreased the titer of TNF. When the lipoxygenase inhibitors were tested in macrophage cultures stimulated with LPS, they prevented the production of TNF. Indomethacin, a blocker of cyclooxygenase was neither in vivo nor in vitro effective in the prevention of the endotoxin-induced synthesis of TNF. The involvement of superoxide anion in this effect was excluded by use of superoxide dismutase which did not influence the formation of TNF in macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494996     DOI: 10.1016/0006-291x(89)90058-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  Mononuclear phagocytes and eicosanoids: aspects of their synthesis and biological activities.

Authors:  U F Schade; I Burmeister; E Elekes; R Engel; D T Wolter
Journal:  Blut       Date:  1989-12

3.  Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice.

Authors:  M Ogata; T Matsumoto; M Kamochi; S I Yoshida; Y Mizuguchi; A Shigematsu
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Colchicine prevents tumor necrosis factor-induced toxicity in vivo.

Authors:  G Tiegs; M A Freudenberg; C Galanos; A Wendel
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

Authors:  R Beyaert; C De Potter; B Vanhaesebroeck; F Van Roy; W Fiers
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

6.  Systemic tumor necrosis factor-alpha production in experimental colitis.

Authors:  D R Mack; A S Lau; P M Sherman
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

7.  Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids.

Authors:  M L Ferrándiz; S J Foster
Journal:  Agents Actions       Date:  1991-03

8.  Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment.

Authors:  M Ogata; S Yoshida; M Kamochi; A Shigematsu; Y Mizuguchi
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Signal transduction pathways involved in tumour necrosis factor secretion by Plasmodium falciparum-stimulated human monocytes.

Authors:  S Picot; I Sheick; A Sylvi; A Donadille; P Ambroise-Thomas
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

10.  An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.

Authors:  M Ogata; T Matsumoto; K Koga; I Takenaka; M Kamochi; T Sata; S Yoshida; A Shigematsu
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.